New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 1, 2012
09:27 EDTSHFL, LIZ, ARCC, RNDY, GPS, LNG, KO, ARNA, DNKN, TIBX, NTAP, RIMM, EMC, DG, AEP, CMI, BBBY, STZ, MON, KMXJim Cramer's "Mad Money"
Jim Cramer said if the Chinese don't deliver on an interest rate cut by Sunday, then Q2 could start out ugly, with less momentum to keep pushing stocks higher. That's why Cramer's game plan for next week's trading was on the cautious side. Cramer said the markets will also be watching the latest German manufacturing numbers. TUESDAY: Cramer said the markets will be watching the latest auto and truck sales. If higher gasoline prices are hurting the U.S. economy, Cramer said it will show up on Tuesday. He told viewers that weak truck sales will be especially bad for Cummins (CMI). WEDNESDAY: Monsanto (MON) and Bed Bath & Beyond (BBBY) reports - Cramer expects good things from both companies and would be a buyer on any weakness from either. THURSDAY: Carmax (KMX) will give another read on the U.S. consumer and higher gas prices. Cramer advised not buying Carmax ahead of the quarter. He was also bullish on Constellation Brands (STZ) and said that the latest retail sales data will make Gap Stores (GPS) the stock to watch in the retail group. FRIDAY: The latest unemployment numbers being released. Cramer expects weakness from the decline in oil and gas drilling, thanks to America's inept energy policy. IPOs: Cramer told viewers to get in on Retail Properties of America, which will begin trading under the ticker RPAI. EXECUTIVE DECISION: Cramer checked in with Nick Akins, president and CEO of American Electric Power (AEP), one of America's top generators of electricity and a company with a 4.9% dividend yield. The shares are down 6.6% for the year over concerns that 65% of the company's power is derived from coal. Cramer said that AEP remains a great, solid company with a great yield, one that deserves a spot in every investor's portfolio. Cramer also spoke with Vivek Ranadive, chairman and CEO of TIBCO Software (TIBX), whose shares fall 6% Friday after it reported a 1c earnings beat on higher-than-expected revenue. Shares of TIBCO, a big data analytics provider, are up 27% since Cramer last spoke with Ranadive on Jan. 11. Ranadive was very bullish on TIBCO's prospects and Cramer remained bullish on TIBCO. MAD TWEETS: Cramer said that no investor should ever have more than 20% of his or her portfolios in speculative stocks. He recommended Roundy's Supermarket (RNDY), a little-known midwest supermarket purveyor with 159 locations under five different brands. Roundy's came public to little fanfare on Feb. 7 and after a modest 6% rise on its first day, shares have been creeping higher, up 26% so far. But what makes Roundy's unique, said Cramer, is its incredible 8.5% dividend yield, one that's triple the industry average. Roundy's, which trades at a scant 7x earnings, is far too cheap, given the company's 10% growth rate. NO HUDDLE OFFENSE: Cramer sounded off against the critics who feel that red-hot IPOs are a sign the markets have gotten too hot to handle. Cramer said nothing could be farther from the truth, as the big secondary offerings from Dollar General (DG) and Dunkin Brands (DNKN) proved this week. Both offerings immediately turned a profit for those who got in on the deal. LIGHTNING ROUND: (Bullish) ARCC; EMC; ARNA. (Bearish) LIZ; RIMM; KO; SHFL; NTAP; LNG. Reference Link
News For CMI;MON;BBBY;KMX;STZ;GPS;AEP;TIBX;RNDY;DG;DNKN;ARCC;EMC;ARNA;LIZ;RIMM;KO;SHFL;NTAP;LNG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
May 12, 2015
10:01 EDTGPSOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AG Mortgage (MITT) downgraded to Market Perform from Outperform at Keefe Bruyette... Brookfield Renewable (BEP) downgraded to Underperform from Neutral at Credit Suisse... Emera (EMRAF) downgraded to Equal Weight from Overweight at Barclays... Fibria Celulose (FBR) downgraded to Neutral from Buy at Citigroup... First Marblehead (FMD) downgraded to Neutral from Buy at Compass Point... First Security (FSGI) downgraded to Market Perform from Outperform at Raymond James... Gap (GPS) downgraded to Market Perform from Outperform at FBR Capital... Intelsat (I) downgraded to Underweight from Equal Weight at Morgan Stanley... LivePerson (LPSN) downgraded to Neutral from Outperform at Credit Suisse... MercadoLibre (MELI) downgraded on valuation, difficult comps at Stifel... Midway Gold (MDW) downgraded to Underperform from Outperform at RBC Capital... Numerex (NMRX) downgraded to Market Perform from Outperform at Northland... Portland General Electric (POR) downgraded to Neutral from Overweight at JPMorgan... Rackspace (RAX) downgraded to Outperform from Buy at CLSA... Rosetta Resources (ROSE) downgraded to Sector Weight from Overweight at KeyBanc... SouFun (SFUN) downgraded to Hold from Buy at Deutsche Bank... Verizon (VZ) downgraded to Underperform from Neutral at Macquarie.
09:14 EDTKOApps World to hold a conference
Subscribe for More Information
07:28 EDTKOMonster Beverage deal financials better than expected, says JPMorgan
Subscribe for More Information
06:24 EDTGPSGap downgraded to Market Perform from Outperform at FBR Capital
Subscribe for More Information
May 11, 2015
19:15 EDTARNAOn The Fly: After Hours Movers
Subscribe for More Information
18:24 EDTSTZConstellation Brands names Jared Fix Chief Marketing Officer for Wine & Spirits
Subscribe for More Information
17:55 EDTGPSGap price target lowered to $44 from $47 at Cantor
Subscribe for More Information
16:41 EDTARNAArena Pharmaceuticals reports Q1 EPS (10c), consensus (14c)
Subscribe for More Information
16:22 EDTARNAArena Pharmaceuticals enters collaboration with Roivant Sciences
Arena Pharmaceuticals announced that its subsidiary, Arena Pharmaceuticals GmbH, and Roivant Sciences Ltd., have entered into a Development, Marketing and Supply Agreement for nelotanserin, Arena's internally discovered inverse agonist of the 5-HT2A receptor. The agreement grants Roivant exclusive worldwide rights to develop and commercialize nelotanserin. Nelotanserin has been studied to date in multiple clinical trials involving over 900 subjects. Roivant intends to initiate additional Phase 2 clinical trials for the treatment of behavioral and neuropsychiatric disturbances, including psychoses, in patients with dementia and other neurological diseases. In addition, Roivant may pursue the development of nelotanserin for other neuropsychiatric disorders. Roivant will be responsible for funding the development and commercialization of nelotanserin. Under the agreement, Arena will manufacture clinical supply and commercial product to sell to Roivant. Arena will receive a $4.0M upfront payment and is eligible to receive $41.5M in regulatory and development milestone payments. Arena is also eligible to receive 15% of net sales of nelotanserin in exchange for the manufacture and supply of finished commercial drug product, and up to a total of $60.0M in one-time purchase price adjustment payments tied to certain commercial sales milestones.
16:06 EDTGPSGap down 1.2% after reporting April, Q1 same-store sales
Subscribe for More Information
16:05 EDTGPSGap sees Q1 EPS 55c-56c, consensus 55c
Subscribe for More Information
16:04 EDTGPSGap reports Q1 SSS down 4%
Gap reported Q1 net sales decreased 3% to $3.66B, compared with $3.77B for the first quarter last year. The translation of net sales in foreign currencies into U.S. dollars negatively impacted the company’s reported sales for Q1 by about $90M, primarily due to the weakening Japanese yen and Canadian dollar. On a constant currency basis, net sales for the first quarter of fiscal year 2015 decreased 1% compared with last year. Gap Inc.’s comparable sales for Q1 were down 4%, versus negative 1% last year. Comparable sales by global brand for the first quarter were as follows: Gap Global: negative 10%; Banana Republic Global: negative 8%; Old Navy Global: positive 3%.
16:02 EDTGPSGap reports April SSS down 12%
Subscribe for More Information
09:59 EDTNTAPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:29 EDTNTAPNetApp cut to sell on competition concerns at Pacific Crest
Pacific Crest downgraded NetApp (NTAP) to Underperform from Sector Perform saying the company's competitive threats are likely to increase this summer with new storage appliances from Nimble (NBML), Pure, Nutanix, Solidfire and Tintri as well as Amazon entering the Cloud network-attached storage space. The assigns a fair value target of $32 for shares. NetApp closed Friday up 8c to $35.65.
06:34 EDTNTAPNetApp downgraded to Underperform from Sector Perform at Pacific Crest
06:33 EDTKMXCarMax management to meet with Oppenheimer
Subscribe for More Information
05:35 EDTMONSyngenta upgraded to Buy from Neutral at UBS
UBS upgraded Syngenta (STY) to Buy saying Monsanto (MON) is likely to raise its takeover bid for the company. The firm views antirust issues as manageable and believes Monsanto could offer as much as CHF535 per share for Syngenta.
May 10, 2015
17:23 EDTMONSyngenta does not consider Monsanto deal dead, Reuters says
Monsanto (MON) remains committed to acquiring Syngenta (SYT) despite having its $45B offer rejected, Reuters reported Friday, citing sources close to each company. A source familiar with Syngenta said the firm does not consider the deal dead. Reference Link
12:54 EDTAEPDuke, Edison, other utilities could return 8% annually, Barron's says
Shares of Duke Energy (DUK), Southern Company (SO), Consolidated Edison (ED), Edison International (EIX), PG&E (PCG), American Electric (AEP), Dominion (D), and NextEra Energy (NEE) could return 8% or more annually in coming years, Barron's contends in a feature article. Though utilities are sometimes seen as no-growth businesses, Barron's argues that infrastructure replacement projects, rate hikes, and dividend boosts make the sector look attractive. Reference Link
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use